Immunological Activity of Chondroitin Sulfate

Advances in Pharmacology

Volumn 53, Issue , 2006, Pages 403-415

  Toida, Toshihiko ^a   Sakai, Shinobu ^a   Akiyama, Hiroshi ^b   Linhardt, Robert J ^c  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; CYTOKINE;

ANIMAL; ARTHRITIS; BIOSYNTHESIS; DRUG EFFECT; HUMAN; IMMUNOLOGY; METABOLISM; ORAL DRUG ADMINISTRATION; REVIEW; TH1 CELL; TH2 CELL;

ADMINISTRATION, ORAL; ANIMALS; ARTHRITIS; CHONDROITIN SULFATES; CYTOKINES; HUMANS; TH1 CELLS; TH2 CELLS;

EID: 33846134763     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(05)53019-9     Document Type: Review

References (56)

1. Adebowale A.O., Cox D.S., Liang Z., and Eddington N.D. Analysis of glucosamine and chondroitin sulfate content in marketed products and the Caco-2 permeability of chondroitin sulfate raw materials. J. Am. Nutrac. Assoc. 3 (2000) 37-44
2. Akiyama H., Hoshino K., Tokuzumi M., Teshima R., Mori H., Inakuma T., Ishiguro Y., Goda Y., Sawada J., and Toyoda M. The effect of feeding carrots on immunoglobulin E production and anaphylactic response in mice. Biol. Pharm. Bull. 22 (1999) 551-555
3. Akiyama H., Sakai S., Linhardt R.J., Goda Y., Toida T., and Maitani T. Chondroitin sulphate structure affects its immunological activities on murine splenocytes sensitized with ovalbumin. Biochem. J. 382 (2004) 269-278
4. Alves A.P., Mulloy B., Diniz J.A., and Mourao P.A.S. Sulphated polysaccharides from the egg jelly layer are species-specific inducers of acrosomal reaction in sperms of sea urchins. J. Biol. Chem. 272 (1997) 6965-6971
5. Arner E.C. Aggrecanase-mediated cartilage degradation. Curr. Opin. Pharmacol. 2 (2002) 322-329
6. Baici A., Horler D., Moser B., Hofer H.O., Fehr K., and Wagenhauser F.J. Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulfate. Rheumatol. Int. 13 (1993) 39-43
7. Baker Jr. C.L., and Ferguson C.M. Future treatment of osteoarthritis. Orthopedics 28 Suppl. 2 (2005) s227-s234
8. Bartolucci C., Cellai L., Corradini C., Corradini D., Lamba D., and Velona I. Chondroprotective action of chondroitin sulfate: Competitive action of chondroitin sulfate on the digestion of hyaluronan by bovine testicular hyaluronidase. Int. J. Tissue Reac. 13 (1991) 311-317
9. Bassleer C., Henrotin Y., and Franchiment P. In-vitro evaluation of drugs proposed as chondroprotective agents. Int. J. Tissue Reac. 14 (1992) 231-241
10. Canapp S.O., McLaughlin Jr. R.M., Hoskinson J.J., Roush J.K., and Butine M.D. Scintigraphic evaluation of dogs with acute synovitis after treatment with glucosamine hydrochloride and chondroitin sulfate. Am. J. Vet. Res. 60 (1999) 1552-1557
11. Capila I., and Linhardt R.J. Heparin-protein interactions. Angew. Chem. 41 (2002) 391-412
12. Chaidedgumjorn A., Toyoda H., Woo E.R., Lee K.B., Kim Y.S., Toida T., and Imanari T. Effect of (1-3)- and (1-4)-linkages of fully sulphated polysaccharides on their anticoagulant activity. Carbohydr. Res. 337 (2002) 925-933
13. Conte A., Palmieri L., Segnini D., and Ronca G. Metabolic fate of partially depolymerized chondroitin sulfate administered to the rat. Drugs Exp. Clin. Res. 17 (1991) 27-33
14. Conte A., Volpi N., Palmieri L., Bahous I., and Ronca G. Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate. Arzneim. Forsch. 45 (1995) 918-925
15. David S.H., and Lynne C.J. Glucosamine and chondroitin sulfate are effective in the management of osteoarthritis. J. Arthro. 18 Suppl. 1 (2003) 5-9
16. De los Reyes G.C., Koda R.T., and Lien E.J. Glucosamine and chondroitin sulfates in the treatment of osteoarthritis: A survey. Prog. Drug Res. 55 (2000) 81-103
17. Dechant J.E., Baxter G.M., Frisbie D.D., Trotter G.W., and McIlwraith C.W. Effects of glucosamine hydrochloride and chondroitin sulphate, alone and in combination, on normal and interleukin-1 conditioned equine articular cartilage explant metabolism. Equine Vet. J. 37 (2005) 227-231
18. Farias W.R., Valente A., Pereira M.S., and Mourao P.A.S. Structure and anticoagulant activity of sulphated galactans. Isolation of a unique sulphated galactan from the red algae Botryocladia occidentalis and comparison of its anticoagulant action with that of sulphated galactans from invertebrates. J. Biol. Chem. 275 (2000) 29299-29307
19. In: Freeman M.A.R. (Ed). "Adult Articular Cartilage." (1979), Pitman Medical Publishing Company, London
20. Jimenez S.A. The effects of glucosamine on human chondrocyte gene expression. "The Ninth Eular Symposium,". Madrid, European League Against Rheumatism, October 8-10 (1996) 8
21. Kawashima H., Li Y.F., Watanabe N., Hirose J., Hirose M., and Miyasaka M. Identification and characterization of ligands for L-selectin in the kidney. I. Versican, a large chondroitin sulphate proteoglycan, is a ligand for L-selectin. Int. Immunol. 11 (1999) 393-405
22. Kawashima H., Hirose M., Hirose J., Nagakubo D., Plaas A.H.K., and Miyasaka M. Binding of a large chondroitin sulphate/dermatan sulphate proteoglycan, versican, to L-selectin, P-selectin, and CD44. J. Biol. Chem. 275 (2000) 35448-35456
23. Kawashima H., Atarashi K., Hirose M., Hirose J., Yamada S., Sugahara K., and Miyasaka M. Oversulphated chondroitin/dermatan sulphates containing GlcAβ1/IdoAa1-3GalNAc(4,6-O-disulphate) interact with L- and P-selectin and chemokines. J. Biol. Chem. 277 (2002) 12921-12930
24. Koyanagi S., Tanigawa N., Nakagawa H., Soeda S., and Shimeno H. Oversulphation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem. Pharmacol. 65 (2003) 173-179
25. Hirose J., Kawashima H., Yoshie O., Tashiro K., and Miyasaka M. Versican interacts with chemokines and modulates cellular responses. J. Biol. Chem. 276 (2001) 5228-5234
26. Hong S.W., Kim B.T., Shin H.Y., Kim W.S., Lee K.S., Kim Y.S., and Kim D.H. Purification and characterization of novel chondroitin ABC and AC lyases from Bacteroides stercoris HJ-15, a human intestinal anaerobic bacterium. Eur. J. Biochem. 269 (2002) 2934-2940
27. Hungerford M.W., and Valaik D. Chondroprotective agents: Glucosamine and chondroitin. Foot Ankle Clin. 28 (2003) 201-219
28. Leeb B.F., Schweitzer H., Montag K., and Smolen J.S. A meta-analysis of chondroitin sulphate in the treatment of osteoarthritis. J. Rheumatol. 27 (2000) 205-211
29. Linhardt R.J., and Toida T. Heparin oligosaccharides: New analogs development and applications. In: Witczak Z.B., and Nieforth K.A. (Eds). "Carbohydrates as Drugs" (1997), Marcel Dekker, New York 277-341
30. Lippiello L., Idouraine A., McNamara P.S., Barr S.C., and McLaughlin R.M. Cartilage stimulatory and antiproteolytic activity is present in sera of dogs treated with a chondroprotective agent. Canine Prac. 24 (1999) 18-20
31. Lippiello L., Woodward J., Karpman R., and Hammad T.A. In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate. Clin. Orthop. Relat. Res. 381 (2000) 229-240
32. McAlindon T.E., LaValley M.P., Gulin J.P., and Felson D.T. Glucosamine and chondroitin for treatment of osteoarthritis. A systemic quality assessment and meta-analysis. J. Am. Med. Assoc. 283 (2000) 1469-1475
33. Morrison M. Therapeutic applications of chondroitin-4-sulfate, appraisal of biological properties. Folia Angiol. 25 (1977) 225-232
34. Mossmann R.T., and Coffman L.R. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7 (1989) 145-173
35. Mossmann R.T., and Coffman L.R. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46 (1989) 111-147
36. Muir H. Current and future trends in articular cartilage research and osteoarthritis. In: Kuettner K.E., Schleyerbach R., and Hascall V.C. (Eds). "Articular Cartilage and Osteoarthritis" (1986), Raven Press, New York 423
37. Nagafuchi S., Hachimura S., Totsuka M., Takahashi T., Goto M., Yajima T., Kuwata T., Habu S., and Kaminogawa S. Dietary nucleotides can up-regulate antigen-specific Th1 immune responses and suppress antigen-specific IgE responses in mice. Int. Arch. Allergy Immunol. 122 (2000) 33-41
38. Ohhashi Y., Hasumi F., and Mori Y. Comparative study on glycosaminoglycans synthesized in peripheral and peritoneal polymorphonuclear leucocytes from guinea pigs. Biochem. J. 217 (1984) 199-207
39. Owens S., Wagner P., and Vangsness Jr. C.T. Recent advances in glucosamine and chondroitin supplementation. J. Knee Surg. 17 (2004) 185-193
40. Petersen R.L., Brandt E., Lindahl U., and Spillmann D. Characterization of a neutrophil cell surface glycosaminoglycan that mediates binding of platelet factor 4. J. Biol. Chem. 274 (1999) 12376-12382
41. Raiss R. Einfluss von D-glucosamin sulfat auf experimenteil geschaedigten gelenkknorpel. Fortschritte der Midizin 103 (1985) 658
42. Richy F., Bruyere O., Ethgen O., Cucherat M., Henrotin Y., and Reginster J.Y. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: A comprehensive meta-analysis. Arch. Int. Med. 163 (2003) 1514-1522
43. Ronca G., and Conte A. Metabolic fate of partially depolymerized shark chondroitin sulfate in man. Int. J. Clin. Pharmacol. Res. 13 Suppl. (1993) 27-34
44. Ronca F., Palmieri L., Panicucci P., and Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage 6 Suppl. A (1998) 14-21
45. Sakai S., Akiyama H., Harikai N., Toyoda H., Toida T., Maitani T., and Imanari T. Effect of chondroitin sulfate on murine splenocytes sensitized with ovalbumin. Immunol. Lett. 84 (2002) 211-216
46. Sakai S., Onose J., Nakamura N., Toyoda H., Toida T., Imanari I., and Linhardt R.J. Pretreatment procedure for the microdetermination of chondroitin sulphate in plasma and urine. Anal. Biochem. 302 (2002) 169-174
47. Santos J.A., Mulloy B., and Mourao P.A.S. Structural diversity among sulphated a-L-galactans from ascidians (tunicates). Studies on the species Ciona intestinalis and Herdmania monus. Eur. J. Biochem. 204 (1992) 669-677
48. Scott D., Smith C., Lohmander S., and Chard J. Osteoarthritis. Clin. Evid. 10 (2005) 1402-1430
49. Stevens R.L., Fox C.C., Lichtenstein L.M., and Austen K.F. Identification of chondroitin sulphate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells. Proc. Natl. Acad. Sci. USA 85 (1988) 2284-2287
50. Suzuki S., Satio H., Yamagata T., Anno K., Seno N., Kawai Y., and Furuhashi T. Formation of three types of disulphated disaccharides from chondroitin sulphates by chondroitinase digestion. J. Biol. Chem. 243 (1968) 1543-1550
51. Suzuki A., Toyoda H., Toida T., and Imanari T. Preparation and inhibitory activity on hyaluronidase of fully O-sulfated hyaluro-oligosaccharides. Glycobiology 11 (2001) 57-64
52. Toida T., Maruyama T., Ogita Y., Suzuki A., Toyoda H., Imanari T., and Linhardt R.J. Preparation and anticoagulant activity of fully O-sulphonated glycosaminoglycans. Int. J. Biol. Macromol. 26 (1999) 233-241
53. Toida T., Suzuki A., Nakajima K., Chaidedgumjorn A., and Imanari T. Effect of 6-O-sulfonate hexosamine residue on anticoagulant activity of fully O-sulfonated glycosaminoglycans. Glycoconj. J. 17 (2000) 393-399
54. Uebelhart D., Thonar E.J., Zhang J., and Williams J.M. Protective effect of exogenous chondroitin 4,6-sulfate in the acute degradation of articular cartilage in the rabbit. Osteoarthritis Cartilage 6 (1998) 39-46
55. Web site. http://www.niams.nih.gov/ne/press/2000/gait_qa.htm#what
56. Wrenshall L.E., Stevens R.B., Cerra F.B., and Platt J.L. Modulation of macrophage and B cell function by glycosaminoglycans. J. Leukoc. Biol. 66 (1999) 391-400